Did Hedge Funds Catch A Break With Catalent Inc (CTLT)?
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 867 13F filings that hedge funds and well-known value investors are required to file by the SEC.
Catalent Inc. (CTLT)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Ophir Asset Management Steven Ng And Andrew Mitchell | 200,000 | $11,760,000 | 2.41% | |
| 2. | Montanaro Asset Management Charles Montanaro | 158,500 | $17,005 | +55% | 2.55% |
| 3. | McKinley Capital Management Robert B. Gillam | 65,317 | $7,008 | -20% | 0.91% |
| 4. | Sciencast Management Qing Li | 7,775 | $884 | -3% | 0.19% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $59.71 | 2,000 | Director | 40,921 | 2020-02-13 | Filing | |
| $51.64 | 2,000 | Director | 38,921 | 2019-09-09 | Filing | |
| $45.13 | 44,500 | Officer | 44,500 | 2019-05-29 | Filing | |
| $44.44 | 10,000 | Director | 46,958 | 2019-05-15 | Filing | |
| $45.08 | 2,000 | Director | 38,822 | 2019-05-09 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $106.90 | 323 | Officer | 13,455 | 2022-07-26 | Filing | |
| $106.90 | 427 | Officer | 15,337 | 2022-07-26 | Filing | |
| $106.90 | 816 | Officer, Director | 25,083 | 2022-07-26 | Filing | |
| $107.67 | 591 | Officer | 17,095 | 2022-07-27 | Filing | |
| $106.90 | 312 | Officer | 17,035 | 2022-07-26 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 27,652 | $2,966,783 | 0.02% | |
| 2. | 6,892,041 | $739,447 | 5.51% | |
| 3. | 1,293,950 | $138,828 | 1.93% | |
| 4. | 1,291,385 | $138,553 | 0.16% | |
| 5. | 1,018,804 | $109,308 | 1.07% |
News See All
Should You Invest Your Hard Earned Cash in Catalent (CTLT)?
ClearBridge Investments, an investment management firm, published its “SMID Cap Growth Strategy” third quarter 2021 investor letter – a copy of which can be downloaded here.
Hedge Funds Are Cashing Out Of Catalent Inc (CTLT)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Top 10 Stock Picks of Jacob Doft's Highline Capital Management
In this article, we discuss the top 10 stock picks of Jacob Doft's Highline Capital Management.
Hedge Funds Are Piling Into Catalent Inc (CTLT)
In this article we are going to use hedge fund sentiment as a tool and determine whether Catalent Inc (NYSE:CTLT) is a good investment right now.
5 Best Pharmaceutical Stocks to Invest In
Catalent, Inc. (NYSE:CTLT) is an American pharmaceutical company, active in R&D and manufacturing of biologics and gene therapies.
Hedge Funds Are Souring On Catalent Inc (CTLT)
We at Insider Monkey have gone over 866 13F filings that hedge funds and prominent investors are required to file by the SEC.
Is CTLT Stock A Buy or Sell?
After several tireless days we have finished crunching the numbers from nearly 900 13F filings issued by the elite hedge funds and other investment firms that we track at Insider Monkey, which disclosed...
Catalent (CTLT) Shines Bright in Madison Fund's Q4 2020 Portfolio
Madison Funds, an independent investment management firm, published its fourth quarter 2020 “Madison Small Cap Fund” investor letter – a copy of which can be downloaded here.
Is CTLT A Good Stock To Buy Now?
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW).
Billionaire Hedge Funds
